Investor Presentation Q1 2018 Audited Results

III Key Investment Highlights Key Investment Highlights 1 Solid Demographic Profile IN A rapidly growing population coupled with a growing middle class and increasing healthcare awareness, positions Egypt as one of the most attractive consumer markets in the region 2 Attractive Industry 3 Dynamics Strong Market Share A highly defensive sector with significant room for continued growth driven by recent regulatory reforms, increasing incidence of chronic disease, and a surge in generic uptake Fastest growing & 2nd largest player in the market with nationwide geographical coverage and access to over 41k retail pharmacies, hospitals & wholesalers 4 Efficient Business 5 6 Model Operational efficiency driven by best in class supply chain processes Resilient Supply Chain Robust Financial Performance Multi-site operations with highly diversified supplier/client base, covering over 80% of the market SKUs, mitigating any supply chain disruptions and ensuring business continuity Significant top and bottom line growth on the back of recent regulatory reforms and enhanced operational efficiency 7 New Revenue Streams 8 Expansion into higher margin diversified revenue streams to further enhance profitability Experienced Management Team Highly experienced management team that has delivered strong results during challenging times, coupled with strong corporate governance practices backed by notable institutional shareholders ibnsinapharma Source: Company Management & IMS Health 10

View entire presentation